Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors

John O. DiRaddo, Eric J. Miller, Carrie Bowman-Dalley, Barbara Wroblewska, Monica Javidnia, Ewa Grajkowska, Barry B. Wolfe, Dennis C. Liotta and Jarda T. Wroblewski
Molecular Pharmacology September 2015, 88 (3) 450-459; DOI: https://doi.org/10.1124/mol.114.096420
John O. DiRaddo
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric J. Miller
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carrie Bowman-Dalley
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Wroblewska
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Javidnia
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewa Grajkowska
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry B. Wolfe
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis C. Liotta
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarda T. Wroblewski
Department of Chemistry, Emory University, Atlanta, Georgia (J.O.D., E.J.M., D.C.L.); and Department of Pharmacology, Georgetown University, Washington, DC (J.O.D., C.B.-D., B.W., M.J., E.G., B.B.W., J.T.W.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The elemental anion chloride is generally considered a passive participant in neuronal excitability, and has never been shown to function as an agonist in its own right. We show that the antagonist-mediated, glutamate-independent inverse agonism of group II and III metabotropic glutamate (mGlu) receptors results from inhibition of chloride-mediated activation. In silico molecular modeling, site-directed mutagenesis, and functional assays demonstrate (1) that chloride is an agonist of mGlu3, mGlu4, mGlu6, and mGlu8 receptors with its own orthosteric site, and (2) that chloride is not an agonist of mGlu2 receptors. Molecular modeling–predicted and site-directed mutagenesis supported that this unique property of mGlu2 receptors results from a single divergent amino acid, highlighting a molecular switch for chloride insensitivity that is transduced through an arginine flip. Ultimately, these results suggest that activation of group II and III mGlu receptors is mediated not only by glutamate, but also by physiologically relevant concentrations of chloride.

Footnotes

    • Received October 15, 2014.
    • Accepted June 18, 2015.
  • Some information presented herein is in the Ph.D. thesis of J.O.D. (unpublished until July 2015): DiRaddo JO (2013) New Molecular Properties of Metabotropic Glutamate Receptors. Doctoral dissertation, Georgetown University, Washington, DC; and the Ph.D. thesis of E.J.M. (scheduled for August 2015): Miller EJ (2015) Chapter 2: Preferential Activation of Metabotropic Glutamate Receptor 3 Over Metabotropic Glutamate Receptor 2. Ph.D. thesis.

  • Some information was presented by J.O.D. and E.J.M. on September 30, 2014 during a poster session at the 8th International Meeting on Metabotropic Glutamate Receptors. DiRaddo JO, Miller EJ, Bowman-Dalley C, Javidnia M, Grajkowska E, Wroblewska B, Wolfe BB, Liotta DC, Wroblewski JT (2014) Chloride is an Agonist of mGlu3, mGlu4, mGlu6, and mGlu8 Receptors, in 8th International Meeting on Metabotropic Glutamate Receptors; 2014 Sept 28–Oct 3; Taormina, Italy. Miller EJ, DiRaddo JO, Grajkowska E, Wroblewska B, Wolfe BB, Snyder JP, Wroblewski JT, Liotta DC (2014) Structural Basis of Chloride Selectivity Between Group II Metabotropic Glutamate Receptors, in 8th International Meeting on Metabotropic Glutamate Receptors; 2014 Sept 28–Oct 3; Taormina, Italy.

  • dx.doi.org/10.1124/mol.114.096420.

  • ↵Embedded ImageThis article has supplemental material available at molpharm.aspetjournals.org.

  • Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 88 (3)
Molecular Pharmacology
Vol. 88, Issue 3
1 Sep 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Chloride is an Agonist of Group II and III mGlu Receptors

John O. DiRaddo, Eric J. Miller, Carrie Bowman-Dalley, Barbara Wroblewska, Monica Javidnia, Ewa Grajkowska, Barry B. Wolfe, Dennis C. Liotta and Jarda T. Wroblewski
Molecular Pharmacology September 1, 2015, 88 (3) 450-459; DOI: https://doi.org/10.1124/mol.114.096420

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Chloride is an Agonist of Group II and III mGlu Receptors

John O. DiRaddo, Eric J. Miller, Carrie Bowman-Dalley, Barbara Wroblewska, Monica Javidnia, Ewa Grajkowska, Barry B. Wolfe, Dennis C. Liotta and Jarda T. Wroblewski
Molecular Pharmacology September 1, 2015, 88 (3) 450-459; DOI: https://doi.org/10.1124/mol.114.096420
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics